The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 39-46

  Wu, Julie M ^a   Borowitz, Michael J ^a   Weir, Edward G ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

B cell lymphoma; CD71; Flow cytometry

Indexed keywords

CD71 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER GRADING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUMOR CELL; TUMOR DIFFERENTIATION;

EID: 33745766448     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/X8LBRRBBC43PL9HC     Document Type: Article

References (37)

1. Gervasi F, Lo Verso R, Giambanco C, et al. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites. Ann N Y Acad Sci. 2004;1028:457-462.
2. Pinto AE, Cabecadas J, Nobrega SD, et al. Flow cytometric S-phase fraction as a complementary biological parameter for the cytologic grading of non-Hodgkin's lymphoma. Diagn Cytopathol. 2003;29:194-199.
3. Christensson B, Tribukait B, Under I-L, et al. Cell proliferation and DNA content in non-Hodgkin's lymphoma: flow cytometry in relation to lymphoma classification. Cancer. 1986;58:1295-1304.
4. Lehtinen T, Aine R, Lehtinen M, et al. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. J Pathol 1989;157:27-36.
5. Joensuu H, Klemi PJ, Soderstrom KO, et al. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer. 1991;68:1564-1571.
6. Braylan RC, Flow-cytometric DNA analysis in the diagnosis and prognosis of lymphoma. Am J Clin Pathol. 1993;99:374-380.
7. Horii A, Yoshida J, Hattori K, et al. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry. Head Neck. 1998;20:392-398.
8. Schmitt F Tani E, Tribukait B, et al. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates of reactive lymphadenitis and non-Hodgkin's lymphomas. Cytopathology. 1999;10:87-96.
9. Lorand-Metze I, Pereira FG, Costa FP, et al. Proliferation in non-Hodgkin's lymphomas and its prognostic value related to staging parameters. Cell Oncol. 2004;26:63-71.
10. Sutherland R, Della D, Schneider C, et al. Ubiquitous, cell surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981;78:4515-4519.
11. Newman R, Schneider C, Sutherland R, et al. The transferrin receptor. Trends Biochem Sci. 1982;7:397-400.
12. Coding JW, Burns GF. Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells. J Immunol. 1981;127:1256-1258.
13. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA. 1981;78:3039-3043.
14. Omary MB, Trowbridge IS, Minowada J. Human cell-surface glycoprotein with unusual properties. Nature. 1980;286:888-891.
15. Terhorst C, van Agthoven A, LeClair K, et al. Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell. 1981;23:771-780.
16. Judd W, Poodry CA, Strominger JL. Novel surface antigen expressed on dividing cells but absent from non-dividing cells. J Exp Med. 1980;152:1430-1435.
17. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9-22.
18. Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index for erythropoiesis. Blood. 1987;70:1955-1958.
19. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med. 1993;44:63-74.
20. Klemow D, Einsphar D, Brown TA, et al. Serum transferrin receptor measurements in hematologic malignancies. Am J Hematol. 1990;34:193-198.
21. Beguin Y, Lampertz S, Bron D, et al. Serum erythropoietin in chronic lymphocytic leukaemia. Br J Haematol. 1996;93:154-156.
22. Stasi R, Zinzani L, Galieni P, et al. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma. Eur J Haematol 1995;54:9-17.
23. Takubo T, Kumura T, Nakao T, et al. Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies. Acta Haematol. 2000;104:141-143.
24. Bjerner J, Amlie LM, Rusten LS, et al. Serum levels of soluble transferrin receptor correlate with severity of disease but not with iron stores in patients with malignant lymphomas. Tumour Biol. 2002;23:146-153.
25. Larson SM, Rasey JS, Allen DR, et al. Common pathway for rumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. J Natl Cancer Inst. 1980;64:41-53.
26. Feremans W, Bujan W, Neve P, et al. CD71 phenotype and the value of gallium imaging in lymphomas. Am J Hematol. 1991;36:215-216.
27. Nejmeddine F, Raphael M, Martin A, et al. 67Ga scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression. J Nucl Med. 1999;40:40-45.
28. Mitani S, Tango T, Sonobe Y, et al. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas. Int J Hematol 1991;54:385-393.
29. Salter DM, Krajewski AS, Sheehan T, et al. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J Pathol. 1989;159:211-220.
30. Medeiros LJ, Picker LJ, Horning SJ, et al. Transferrin receptor expression by non-Hodgkin's lymphomas: correlation with morphologic grade and survival. Cancer. 1988;61:1844-1851.
31. Pileri S, Gobbi M, Rivano MT, et al. Immunohistological study of transferrin receptor expression in non-Hodgkin's lymphoma. Br J Haematol. 1984;58:501-508.
32. Habeshaw JA, Lister TA, Stansfeld AG, et al. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet. 1983;1:498-501.
33. Hedley DW, Shankey TV, Wheeless LL. DNA cytometry consensus conference. Cytometry. 1993;14:471.
34. Duque RE, Andreeff M, Braylan RC, et al. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry. 1993;14:492-496.
35. Schwarting R, Gerdes J, Niehus J, et al. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods. 1986;90:65-70.
36. Lopez F, Belloc F, Lacombe F, et al. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry. 1991;12:42-49.
37. Van Bockstaele DR, Lan J, Snoeck HW, et al. Aberrant Ki67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis. Cytometry. 1991;12:50-63.